ABBV AbbVie Inc.
As of 11:19:00 AM ET
Loading chart…
- Open
- $292.56
- Previous close
- $294.89
- Day range
- 286.38 – 293.79
- 52-week range
- 190.75 – 298.74
- Volume
- 157K
- Avg volume (3M)
- 4.7M
- Market cap
- $506.1B
- P/E (TTM)
- 81.43
- EPS (TTM)
- $3.54
- Beta
- 0.23
- Dividend yield
- 2.35%
- Next earnings
- —
- Ex-dividend
- Oct 15, 2026
- Sector
- Healthcare
About AbbVie Inc.
AbbVie Inc. is a global biopharmaceutical company that develops, manufactures, and commercializes medicines and therapies for complex and serious diseases. AbbVie focuses on major therapeutic areas including immunology, oncology, neuroscience, eye care, aesthetics, and virology, serving patients with chronic autoimmune conditions, blood cancers, inflammatory disorders, and other specialized medical needs. The company’s portfolio includes branded prescription medicines and advanced therapies distributed through physicians, wholesalers, specialty pharmacies, healthcare facilities, and other healthcare channels. AbbVie also supports contract manufacturing services for selected biologics and pharmaceutical processes. Headquartered in North Chicago, Illinois, AbbVie operates as a research-driven healthcare business with a broad international footprint and a strong role in specialty medicine markets.
| Quarter | EPS estimate | EPS actual | Surprise |
|---|---|---|---|
| Jul 31, 2026(after close) | $3.61 | $3.65 | +1.1% |
| Jun 18, 2026(after close) | $1.59 | $1.58 | −0.6% |
| Apr 28, 2026(after close) | $4.82 | $4.97 | +3.1% |
| Apr 20, 2026(after close) | $0.83 | $0.92 | +10.8% |
- Annual dividend
- $6.92
- Yield
- 2.35%
- Frequency
- Quarterly
- Next ex-date
- —
| Ex-date | Amount |
|---|---|
| Oct 15, 2026 | $1.7300 |
| Jul 15, 2026 | $1.7300 |
| Apr 15, 2026 | $1.7300 |
| Jan 16, 2026 | $1.7300 |
| Oct 15, 2025 | $1.6400 |
| Jul 15, 2025 | $1.6400 |
| Apr 15, 2025 | $1.6400 |
| Jan 15, 2025 | $1.6400 |
| Oct 15, 2024 | $1.5500 |
| Jul 15, 2024 | $1.5500 |
| Apr 12, 2024 | $1.5500 |
| Jan 12, 2024 | $1.5500 |
| Oct 12, 2023 | $1.4800 |
| Jul 13, 2023 | $1.4800 |
| Apr 13, 2023 | $1.4800 |
| Jan 12, 2023 | $1.4800 |
ABBV news and filings
Loading filings…
Filings from SEC EDGAR.